Navigation Links
New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia
Date:5/19/2009

ted that patients with schizophrenia in the Veterans Affairs (VA) system who also suffered from other medical or psychiatric illnesses had fewer and shorter-duration psychiatric hospitalizations after the initiation of RISPERDAL(R) CONSTA(R).

This analysis identified all VA patients with schizophrenia who began RISPERDAL(R) CONSTA(R) between October 1, 2005 and September 30, 2006 and received at least four (total) injections (N=924). The analysis compared changes in health services use between 12 months prior to and 12 months after initiation of RISPERDAL(R) CONSTA(R). Results showed that between the pre- and post- RISPERDAL(R) CONSTA(R) initiation periods, the mean number of psychiatric hospitalizations and length of stay significantly decreased for patients with three or more concurrent illnesses, while psychiatric-related outpatient visits increased.(4)

"The results of this analysis suggest that long-acting therapy may reduce the need for repeated hospitalizations and improve everyday psychiatric follow-up among patients with complex medical histories," continued Dirani.

A limitation of these two studies is that they did not compare RISPERDAL(R) CONSTA(R) to placebo or other treatments.

The studies were presented and sponsored by Ortho-McNeil Janssen ScientificAffairs.

About Schizophrenia

According to the National Institute of Mental Health, an estimated one percent of the U.S. population suffers from schizophrenia - a brain disorder that impairs a person's ability to think clearly, relate to others and distinguish between reality and imagination. It typically develops in adolescence or the early 20s, although symptoms may not become immediately obvious.

About RISPERDAL(R) CONSTA(R)

RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment (RLAT) is a long-acting injectable atypical antipsychotic therapy used for the treatment of
'/>"/>

SOURCE Janssen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
2. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
3. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
4. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
5. Highmarks Hospital Pay-for-Performance Program Demonstrates Impressive Results
6. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
7. STA Travel and Keep a Child Alive Ask College Students to Demonstrate Their Good Cents
8. LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery
11. New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... September 20, 2014 Ticket Down ... tickets . This popular ticket exchange is offering their ... , The 2015 schedule of tours is beginning to fill ... announced their plans to hit the road, including 21-year-old pop ... announced the “Honeymoon Tour,” which will take her to 25 ...
(Date:9/20/2014)... 2014 The print component of ... of the Calgary Herald, with a circulation of ... 270,000. The digital component is distributed nationally through ... network of top news sites and partner outlets. ... visit http://www.worklifebalanceinfo.ca . , The publication features ...
(Date:9/20/2014)... festival season is coming soon. The high-end fashion designer BellasDress ... dresses . A lot of sophisticated women like its new ... promotion for its high quality clothes. Now, each of its ... to 71 percent off. , The company’s cocktail dress ... in many fashionable colors. Mary, the company’s sales manager, believes ...
(Date:9/20/2014)... 2014 iFitDress.com, the popular online supplier ... has recently unveiled its new collection of cocktail gowns. ... special offer on these new outfits; it intends to ... customers can now buy cheap cocktail dresses ... representative says, “We have extensive experience in the industry ...
(Date:9/20/2014)... 20, 2014 "As a nurse, patients always ... said an inventor from Tamaqua, Pa. "The reason that they ... backs of their chairs. My invention enables them to check ... Oxygen Sensor to make it easier to monitor the contents ... knows when the tank is low. It allows changeovers to ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2
... , , , ... leading provider of advanced clinical documentation software, workflow tools, consulting ... as Corporate Vice President of Marketing and Communications. Reporting ... with designing and implementing new marketing initiatives that blend the ...
... NEW ORLEANS, July 29 Smoothie King, the 1973 originator ... leading the way to making healthy alternatives and high-quality meal replacements available ... Consumers in Tokyo will be the first in Japan to enjoy the ... open in 2010. Japan makes sense as the latest Smoothie King market, ...
... HAIKOU CITY, China, July 29 /PRNewswire-Asia-FirstCall/ -- China ... develops,manufactures, and markets specialty pharmaceutical products in China, today,announced ... results on,Wednesday, August 12, 2009, before the market opens. ... a conference call at 8:00 am ET on August ...
... , SOUTH SAN FRANCISCO, Calif., July 29 ... biopharmaceutical company focused on innovative oncology therapies, today announced that ... to provide a corporate overview, including a discussion about the ... at two upcoming investor conferences: , , ...
... chemo, expert says , WEDNESDAY, July 29 (HealthDay News) ... tumors show promise, U.S. researchers report. , The nanoparticles ... fatty molecules that can be designed to carry a ... to control how long they remain in the bloodstream. ...
... , , DARIEN, Conn., July 29 ... Switch , a sparkling 100% juice, is expanding its availability into ... The Switch has added key retailers Tops, D,Agostinos, ... And the list of eager retailers keeps growing with Wegmans, Price ...
Cached Medicine News:Health News:Precyse Solutions Taps Former Siemens Executive to Lead New Marketing Organization 2Health News:Smoothie King Expansion Signals International Trend Toward Healthy Living 2Health News:Smoothie King Expansion Signals International Trend Toward Healthy Living 3Health News:China Pharma Holdings, Inc. to Report Second Quarter 2009 Financial Results on August 12, 2009 2Health News:Poniard Pharmaceuticals to Present at Two Upcoming Investor Conferences in August 2Health News:Scientists Test New Way to Get Drugs to Cancer Cells 2Health News:People Across the Country are Making The Switch! 2
(Date:9/19/2014)... The American Association for Homecare (AAHomecare) is ... has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much of ... grown into a major global manufacturer of home medical ... to increase efforts on behalf of the HME sector ...
(Date:9/19/2014)... 19, 2014 UBM Medica US announces that  ... community to help oncologists and other clinicians gain a ... use of targeted therapies and immunotherapies, discusses some of ... Every September, Blood Cancer Awareness ... awareness about blood cancers—helping to increase survival rates and ...
(Date:9/19/2014)... -- Larry J. Merlo , President and CEO of ... the National Press Club in Washington, D.C. ... stop selling tobacco products and its leadership in driving the ... "Dramatic changes in our health care system pose enormous challenges ... said. "CVS Health has a truly unique combination of business ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
... 2011 Due to significant recent growth in its x-ray ... has announced several changes to its sales and marketing operations. ... distributor and supplier in the newly created position as ... News headquarters. Porter has had experience as a division sales ...
... Vycor Medical, Inc. announces that  Alvaro Pascual-Leone, MD, PhD ... Strategic Advisory Board of its NovaVision, Inc. subsidiary. ... at Harvard Medical School; Director of the Berenson-Allen Center ... Clinical Research Unit; and an Attending Neurologist at Beth ...
Cached Medicine Technology:Burlington Medical Supplies Reorganizes Sales and Marketing Operations 2Vycor Medical, Inc. Announces Alvaro Pascual-Leone, MD, PhD as Head of the Strategic Advisory Board of its NovaVision, Inc. Subsidiary 2Vycor Medical, Inc. Announces Alvaro Pascual-Leone, MD, PhD as Head of the Strategic Advisory Board of its NovaVision, Inc. Subsidiary 3Vycor Medical, Inc. Announces Alvaro Pascual-Leone, MD, PhD as Head of the Strategic Advisory Board of its NovaVision, Inc. Subsidiary 4